000			01926 a2200541 4500
005			20250514222645.0
264		0	_c20050517
008			200505s 0 0 eng d
022			_a0002-9440
024	7		_a10.1016/S0002-9440(10)62322-X _2doi
040			_aNLM _beng _cNLM
100	1		_aBhagavathula, Narasimharao
245	0	0	_aAmphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. _h[electronic resource]
260			_bThe American journal of pathology _cApr 2005
300			_a1009-16 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAmphiregulin
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aCells, Cultured
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEGF Family of Proteins
650	0	4	_aEpidermis _xdrug effects
650	0	4	_aFibroblasts _xdrug effects
650	0	4	_aGlycoproteins _ximmunology
650	0	4	_aHumans
650	0	4	_aHyperplasia _xdrug therapy
650	0	4	_aIntercellular Signaling Peptides and Proteins _ximmunology
650	0	4	_aKeratinocytes _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aPsoriasis _xdrug therapy
650	0	4	_aSkin Transplantation
700	1		_aNerusu, Kamalakar C
700	1		_aFisher, Gary J
700	1		_aLiu, Gao
700	1		_aThakur, Archana B
700	1		_aGemmell, Lorraine
700	1		_aKumar, Shankar
700	1		_aXu, Zenghai H
700	1		_aHinton, Paul
700	1		_aTsurushita, Naoya
700	1		_aLandolfi, Nicholas F
700	1		_aVoorhees, John J
700	1		_aVarani, James
773	0		_tThe American journal of pathology _gvol. 166 _gno. 4 _gp. 1009-16
856	4	0	_uhttps://doi.org/10.1016/S0002-9440(10)62322-X _zAvailable from publisher's website
999			_c15464086 _d15464086